The Arizona Emergency Medicine Research Center, College of Medicine, The University of Arizona, Tucson, AZ; The Department of Emergency Medicine, College of Medicine, The University of Arizona, Tucson, AZ.
Acad Emerg Med. 2014 Jul;21(7):818-30. doi: 10.1111/acem.12411. Epub 2014 Aug 11.
Traumatic brain injury (TBI) exacts a great toll on society. Fortunately, there is growing evidence that the management of TBI in the early minutes after injury may significantly reduce morbidity and mortality. In response, evidence-based prehospital and in-hospital TBI treatment guidelines have been established by authoritative bodies. However, no large studies have yet evaluated the effectiveness of implementing these guidelines in the prehospital setting. This article describes the background, design, implementation, emergency medical services (EMS) treatment protocols, and statistical analysis of a prospective, controlled (before/after), statewide study designed to evaluate the effect of implementing the EMS TBI guidelines-the Excellence in Prehospital Injury Care (EPIC) study (NIH/NINDS R01NS071049, "EPIC"; and 3R01NS071049-S1, "EPIC4Kids"). The specific aim of the study is to test the hypothesis that statewide implementation of the international adult and pediatric EMS TBI guidelines will significantly reduce mortality and improve nonmortality outcomes in patients with moderate or severe TBI. Furthermore, it will specifically evaluate the effect of guideline implementation on outcomes in the subgroup of patients who are intubated in the field. Over the course of the entire study (~9 years), it is estimated that approximately 25,000 patients will be enrolled.
创伤性脑损伤 (TBI) 给社会带来了巨大的损失。幸运的是,越来越多的证据表明,在受伤后的最初几分钟内对 TBI 进行管理可以显著降低发病率和死亡率。因此,权威机构已经制定了基于循证的院前和院内 TBI 治疗指南。然而,还没有大型研究评估在院前环境中实施这些指南的效果。本文描述了一项前瞻性、对照(前后)、全州范围的研究的背景、设计、实施、紧急医疗服务 (EMS) 治疗方案以及统计分析,该研究旨在评估实施 EMS TBI 指南的效果——卓越院前伤害护理 (EPIC) 研究(NIH/NINDS R01NS071049,“EPIC”;和 3R01NS071049-S1,“EPIC4Kids”)。该研究的具体目的是检验假设,即在全州范围内实施国际成人和儿科 EMS TBI 指南将显著降低中度或重度 TBI 患者的死亡率并改善非死亡率结局。此外,它将特别评估指南实施对在现场插管的患者亚组的效果。在整个研究期间(约 9 年),预计将有大约 25000 名患者入组。